Illinois 2023-2024 Regular Session

Illinois Senate Bill SB3304 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB3304 Introduced 2/7/2024, by Sen. Suzy Glowiak Hilton SYNOPSIS AS INTRODUCED: 720 ILCS 570/311.6 Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of this Section occurs. Effective immediately. LRB103 37507 RLC 69488 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB3304 Introduced 2/7/2024, by Sen. Suzy Glowiak Hilton SYNOPSIS AS INTRODUCED: 720 ILCS 570/311.6 720 ILCS 570/311.6 Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of this Section occurs. Effective immediately. LRB103 37507 RLC 69488 b LRB103 37507 RLC 69488 b A BILL FOR
2	2	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB3304 Introduced 2/7/2024, by Sen. Suzy Glowiak Hilton SYNOPSIS AS INTRODUCED:
3	3	720 ILCS 570/311.6 720 ILCS 570/311.6
4	4	720 ILCS 570/311.6
5	5	Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of this Section occurs. Effective immediately.
6	6	LRB103 37507 RLC 69488 b LRB103 37507 RLC 69488 b
7	7	LRB103 37507 RLC 69488 b
8	8	A BILL FOR
9	9	SB3304LRB103 37507 RLC 69488 b SB3304 LRB103 37507 RLC 69488 b
10	10	SB3304 LRB103 37507 RLC 69488 b
11	11	1 AN ACT concerning criminal law.
12	12	2 Be it enacted by the People of the State of Illinois,
13	13	3 represented in the General Assembly:
14	14	4 Section 5. The Illinois Controlled Substances Act is
15	15	5 amended by changing Section 311.6 as follows:
16	16	6 (720 ILCS 570/311.6)
17	17	7 Sec. 311.6. Opioid prescriptions.
18	18	8 (a) Notwithstanding any other provision of law, a
19	19	9 prescription for a substance classified in Schedule II, III,
20	20	10 IV, or V must be sent electronically, in accordance with
21	21	11 Section 316. Prescriptions sent in accordance with this
22	22	12 subsection (a) must be accepted by the dispenser in electronic
23	23	13 format.
24	24	14 (b) Beginning on the effective date of this amendatory Act
25	25	15 of the 103rd General Assembly until December 31, 2028,
26	26	16 notwithstanding any other provision of this Section or any
27	27	17 other provision of law, a prescriber shall not be required to
28	28	18 issue prescriptions electronically if he or she certifies to
29	29	19 the Department of Financial and Professional Regulation that
30	30	20 he or she will not issue more than 150 prescriptions during a
31	31	21 12-month period. Prescriptions in both oral and written form
32	32	22 for controlled substances shall be included in determining
33	33	23 whether the prescriber will reach the limit of 150
34	34
35	35
36	36
37	37	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB3304 Introduced 2/7/2024, by Sen. Suzy Glowiak Hilton SYNOPSIS AS INTRODUCED:
38	38	720 ILCS 570/311.6 720 ILCS 570/311.6
39	39	720 ILCS 570/311.6
40	40	Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of this Section occurs. Effective immediately.
41	41	LRB103 37507 RLC 69488 b LRB103 37507 RLC 69488 b
42	42	LRB103 37507 RLC 69488 b
43	43	A BILL FOR
44	44
45	45
46	46
47	47
48	48
49	49	720 ILCS 570/311.6
50	50
51	51
52	52
53	53	LRB103 37507 RLC 69488 b
54	54
55	55
56	56
57	57
58	58
59	59
60	60
61	61
62	62
63	63	SB3304 LRB103 37507 RLC 69488 b
64	64
65	65
66	66	SB3304- 2 -LRB103 37507 RLC 69488 b SB3304 - 2 - LRB103 37507 RLC 69488 b
67	67	SB3304 - 2 - LRB103 37507 RLC 69488 b
68	68	1 prescriptions. Beginning January 1, 2029, notwithstanding any
69	69	2 other provision of this Section or any other provision of law,
70	70	3 a prescriber shall not be required to issue prescriptions
71	71	4 electronically if he or she certifies to the Department of
72	72	5 Financial and Professional Regulation that he or she will not
73	73	6 issue more than 50 prescriptions during a 12-month period.
74	74	7 Prescriptions in both oral and written form for controlled
75	75	8 substances shall be included in determining whether the
76	76	9 prescriber will reach the limit of 50 prescriptions.
77	77	10 (b-5) Notwithstanding any other provision of this Section
78	78	11 or any other provision of law, a prescriber shall not be
79	79	12 required to issue prescriptions electronically under the
80	80	13 following circumstances:
81	81	14 (1) prior to January 1, 2026, the prescriber
82	82	15 demonstrates financial difficulties in buying or managing
83	83	16 an electronic prescription option, whether it is an
84	84	17 electronic health record or some other electronic
85	85	18 prescribing product;
86	86	19 (2) on and after January 1, 2026, the prescriber
87	87	20 provides proof of a waiver from the Centers for Medicare
88	88	21 and Medicaid Services for the Electronic Prescribing for
89	89	22 Controlled Substances Program due to demonstrated economic
90	90	23 hardship for the previous compliance year;
91	91	24 (3) there is a temporary technological or electrical
92	92	25 failure that prevents an electronic prescription from
93	93	26 being issued;
94	94
95	95
96	96
97	97
98	98
99	99	SB3304 - 2 - LRB103 37507 RLC 69488 b
100	100
101	101
102	102	SB3304- 3 -LRB103 37507 RLC 69488 b SB3304 - 3 - LRB103 37507 RLC 69488 b
103	103	SB3304 - 3 - LRB103 37507 RLC 69488 b
104	104	1 (4) the prescription is for a drug that the
105	105	2 practitioner reasonably determines would be impractical
106	106	3 for the patient to obtain in a timely manner if prescribed
107	107	4 by an electronic data transmission prescription and the
108	108	5 delay would adversely impact the patient's medical
109	109	6 condition;
110	110	7 (5) the prescription is for an individual who:
111	111	8 (A) resides in a nursing or assisted living
112	112	9 facility;
113	113	10 (B) is receiving hospice or palliative care;
114	114	11 (C) is receiving care at an outpatient renal
115	115	12 dialysis facility and the prescription is related to
116	116	13 the care provided;
117	117	14 (D) is receiving care through the United States
118	118	15 Department of Veterans Affairs; or
119	119	16 (E) is incarcerated in a state, detained, or
120	120	17 confined in a correctional facility;
121	121	18 (6) the prescription prescribes a drug under a
122	122	19 research protocol;
123	123	20 (7) the prescription is a non-patient specific
124	124	21 prescription dispensed under a standing order, approved
125	125	22 protocol for drug therapy, collaborative drug management,
126	126	23 or comprehensive medication management, or in response to
127	127	24 a public health emergency or other circumstance in which
128	128	25 the practitioner may issue a non-patient specific
129	129	26 prescription;
130	130
131	131
132	132
133	133
134	134
135	135	SB3304 - 3 - LRB103 37507 RLC 69488 b
136	136
137	137
138	138	SB3304- 4 -LRB103 37507 RLC 69488 b SB3304 - 4 - LRB103 37507 RLC 69488 b
139	139	SB3304 - 4 - LRB103 37507 RLC 69488 b
140	140	1 (8) the prescription is issued when the prescriber and
141	141	2 dispenser are the same entity;
142	142	3 (9) the prescription is issued for a compound
143	143	4 prescription containing 2 or more compounds; or
144	144	5 (10) the prescription is issued by a licensed
145	145	6 veterinarian within 2 years after the effective date of
146	146	7 this amendatory Act of the 103rd General Assembly.
147	147	8 (c) The Department of Financial and Professional
148	148	9 Regulation may adopt rules for the administration of this
149	149	10 Section to the requirements under this Section that the
150	150	11 Department of Financial and Professional Regulation may deem
151	151	12 appropriate.
152	152	13 (d) Any prescriber who makes a good faith effort to
153	153	14 prescribe electronically, but for reasons not within the
154	154	15 prescriber's control is unable to prescribe electronically,
155	155	16 may be exempt from any disciplinary action.
156	156	17 (e) Any pharmacist who dispenses in good faith based upon
157	157	18 a valid prescription that is not prescribed electronically may
158	158	19 be exempt from any disciplinary action. A pharmacist is not
159	159	20 required to ensure or responsible for ensuring the
160	160	21 prescriber's compliance under subsection (b), nor may any
161	161	22 other entity or organization require a pharmacist to ensure
162	162	23 the prescriber's compliance with that subsection. A pharmacist
163	163	24 may not refuse to fill a valid prescription solely because it
164	164	25 is not prescribed electronically.
165	165	26 (f) It shall be a violation of this Section for any
166	166
167	167
168	168
169	169
170	170
171	171	SB3304 - 4 - LRB103 37507 RLC 69488 b
172	172
173	173
174	174	SB3304- 5 -LRB103 37507 RLC 69488 b SB3304 - 5 - LRB103 37507 RLC 69488 b
175	175	SB3304 - 5 - LRB103 37507 RLC 69488 b
176	176	1 prescriber or dispenser to adopt a policy contrary to this
177	177	2 Section.
178	178	3 (g) A compliance action with respect to this Section
179	179	4 initiated by the Department of Financial and Professional
180	180	5 Regulation prior to December 31, 2030 is limited to a
181	181	6 non-disciplinary warning letter or citation, unless the
182	182	7 prescriber fails to abide by the initial non-disciplinary
183	183	8 warning letter or citation, has acted in bad faith, or a
184	184	9 pattern of practice in violation of this Section occurs.
185	185	10 (Source: P.A. 102-490, eff. 1-1-24 (See Section 55 of P.A.
186	186	11 102-1109 for effective date of P.A. 102-490); 103-425, eff.
187	187	12 1-1-24; 103-563, eff. 11-17-23.)
188	188
189	189
190	190
191	191
192	192
193	193	SB3304 - 5 - LRB103 37507 RLC 69488 b